JC
Jonathan Couchman
10% Owner

Jonathan Couchman insider trades: Enzon Pharmaceuticals (ENZN) stock buys and sales

10% Owner, Enzon Pharmaceuticals Last trade Aug 13, 2021 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
8
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

and 2 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 13, 2021ENZN↓ Sell$22K
Aug 13, 2021ENZN↓ Sell$19K
Aug 25, 2020ENZN↓ Sell$14K
Aug 5, 2020ENZN↑ Buy$101K
Mar 26, 2020ENZN↑ Buy$89K
Mar 13, 2020ENZN↑ Buy$3K
Feb 11, 2019ENZN↑ Buy$9K
Feb 11, 2019ENZN↑ Buy$4K
Jan 7, 2019ENZN↑ Buy$27K
Dec 21, 2018ENZN↑ Buy$203K
Aug 14, 2018ENZN↑ Buy$259K
Jun 22, 2005SALDQ.PK↓ Sell$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jonathan Couchman's insider trades

Jonathan Couchman is a 10% owner of Enzon Pharmaceuticals (ENZN). Since Jun 22, 2005, Jonathan has reported 8 open-market purchases worth $694K and 4 sales worth $59K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENZN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.